Datum Källa Rubrik Typ Alternativ
2023-06-02 Genovis Genovis AB: Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets Pressreleaser Ladda ner | Visa Stäng
2023-06-02 Genovis Genovis AB: Genovis lanserar unikt IgM-specifikt enzym med breda tillämpningar inom Life Science-marknaden Pressreleaser Ladda ner | Visa Stäng
2023-05-17 Redeye Redeye: Genovis Q1 2023 - Strongest report to date Pressreleaser Ladda ner | Visa Stäng
2023-05-16 Genovis Communiqué from Genovis AB (publ) Annual General Meeting May 16, 2023 Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 16 May 2023 | Genovis

Communiqué from Genovis AB (publ) Annual General Meeting May 16, 2023

The Annual General Meeting adopted the following resolutions:

  • The Balance Sheet and Income Statement as well as the Consolidated Income Statement and the Consolidated Balance Sheet were adopted.

  • The Board and the Chief Executive Officer were discharged from liability.

  • The Board shall consist until the next AGM of five ordinary members without deputies.

  • Re-election of Board members Torben Jørgensen, Mikael Lönn, Lotta Ljungqvist, Steve Jordan and Magnus Gustafsson.

Torben Jørgensen was elected Chairperson of the Board.

  • Remuneration will be paid to the Board of Directors in the amount of SEK 200,000 to Board members and SEK 400,000 to the Chairperson of the Board. 

  • Remuneration to the auditors will be paid on approved account.  

  • In accordance with the Nomination Committee’s proposal, the Meeting re-elected the accounting firm Öhrlings PricewaterhouseCoopers AB as auditor for the period until the close of the Annual General Meeting 2024.

  • In accordance with the Board’s proposal the Company’s Articles of Association, item 2 and 8, was amended. The Board shall be seated in the Municipality of Kävlinge and the company’s General Meeting can be held at the following locations, Kävlinge and Lund.

  • A Nomination Committee will be formed with representatives of the four largest shareholders at September 30, 2023.

2023-05-16 Genovis Kommuniké från Årsstämman i Genovis AB (publ) den 16 maj 2023 Pressreleaser Ladda ner | Visa Stäng
2023-05-16 Genovis Genovis AB: Interim Report January-March 2023 Rapporter Ladda ner | Visa Stäng
2023-05-16 Genovis Genovis AB: Kvartalsrapport januari-mars 2023 Rapporter Ladda ner | Visa Stäng
2023-05-03 Genovis Genovis AB: Genovis and ArcticZymes Technologies enter into a collaboration agreement to accelerate growth in China Pressreleaser Ladda ner | Visa Stäng
2023-05-03 Genovis Genovis AB: Genovis och ArcticZymes Technologies ingår samarbetsavtal för att accelerera tillväxt på den kinesiska marknaden Pressreleaser Ladda ner | Visa Stäng
2023-04-25 Genovis Genovis AB: Genovis acquires IP Rights to novel enzymes for applications within genomics Pressreleaser Ladda ner | Visa Stäng
2023-04-25 Genovis Genovis AB: Genovis förvärvar patenträttigheter till nytt enzym inom genomics Pressreleaser Ladda ner | Visa Stäng
2023-04-25 Genovis Genovis AB: Genovis årsredovisning 2022 publicerad Pressreleaser Ladda ner | Visa Stäng
2023-04-25 Genovis Genovis AB: Genovis Annual Report 2022 published Pressreleaser Ladda ner | Visa Stäng
2023-04-11 Genovis Genovis AB: NOTICE CONVENING THE 2023 ANNUAL GENERAL MEETING Pressreleaser Ladda ner | Visa Stäng
2023-04-11 Genovis Genovis AB: KALLELSE TILL ÅRSSTÄMMA 2023 Pressreleaser Ladda ner | Visa Stäng
2023-02-16 Redeye Redeye: Genovis Q4 2022 - A First Sublicensing of Xork Pressreleaser Ladda ner | Visa Stäng
2023-02-15 Genovis Genovis AB: Year-end Report January-December 2022 Rapporter Ladda ner | Visa Stäng
2023-02-15 Genovis Genovis AB: Bokslutskommuniké januari-december 2022 Rapporter Ladda ner | Visa Stäng
2023-01-09 Genovis Genovis AB: Genovis erhåller direkt 4 MUSD efter att Selecta Biosciences sub-licensierat Xork™-enzymet till Astellas Pharma Pressreleaser Ladda ner | Visa Stäng
2023-01-09 Genovis Genovis AB: Genovis to receive 4 MUSD upfront after Selecta Biosciences sublicensed Xork™ enzyme to Astellas Pharma Pressreleaser Ladda ner | Visa Stäng
2022-12-12 Redeye Redeye: Genovis - Bull Story, Fair Price Analyser Ladda ner | Visa Stäng
2022-11-15 Genovis Genovis AB: Interim Report January-September 2022 Rapporter Ladda ner | Visa Stäng
2022-11-15 Genovis Genovis AB: Delårsrapport januari-september 2022 Rapporter Ladda ner | Visa Stäng

Kommande händelser

15 May 2024 | Kvartalsrapport 2024-Q1
15 May 2024 | Årsstämma 2024
16 May 2024 | Årligutdelning
20 Aug 2024 | Kvartalsrapport 2024-Q2
8 Nov 2024 | Kvartalsrapport 2024-Q3
14 Feb 2025 | Bokslutskommuniké 2024